Peer-reviewed veterinary case report
Subunit fusion unlocks rapid <i>in vitro</i> maturation for slowly activating heterodimeric [FeFe]-hydrogenases.
- Year:
- 2026
- Authors:
- Jaenecke J et al.
- Affiliation:
- Technical University of Munich · Germany
Abstract
Hydrogenases offer a sustainable alternative to noble metals for catalyzing H<sub>2</sub>-oxidation and H<sub>2</sub>-production. The heterodimeric [FeFe]-hydrogenase of <i>Desulfovibrio desulfuricans</i> ATCC 7757 (<i>Dd</i>HydAB) is most promising due to its exceptional catalytic activity and high-yield heterologous expression of its apo-form. Scalable production of the holo-form relies on <i>in vitro</i> maturation of the apo-enzyme using a chemically synthesized 2Fe<sub>H</sub> cofactor mimic. However, the unusually slow <i>in vitro</i> maturation of <i>Dd</i>HydAB raises mechanistic questions and limits its scalability. Through structural and sequence analysis, we identified the cause of this slow maturation and redesigned the enzyme <i>via</i> subunit fusion, inserting short peptide linkers near the active site. This modification facilitates the rearrangement of a critical locking element after cofactor uptake, increasing the maturation rate by up to 41-fold without compromising catalytic performance. Our findings elucidate a key step in the plug-lock-lid mechanism underlying maturation and promote the industrial applicability of <i>Dd</i>HydAB.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/41756151